Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients
Open Access
- 1 April 1997
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 33 (4) , 602-607
- https://doi.org/10.1016/s0959-8049(96)00486-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Comparison of chemotherapy with or without medroxyprogesterone acetate for advanced or recurrent breast cancerEuropean Journal Of Cancer, 1994
- The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivoCytokine, 1993
- Cytokines and Their Role in the Pathophysiology of Cancer CachexiaJournal of Parenteral and Enteral Nutrition, 1992
- The effect of megestrol acetate on interleukin-1 activityGynecologic Oncology, 1991
- Interleukin-6: An OverviewAnnual Review of Immunology, 1990
- A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Effects of antiestrogen and progestin on immune functions in breast cancer patientsCancer, 1988
- Tumors secreting human TNF/cachectin induce cachexia in miceCell, 1987
- Reduced Plasma Lipoprotein Lipase Activity in Patients with Malignancy-Associated Weight LossHormone and Metabolic Research, 1986
- Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells.The Journal of Experimental Medicine, 1985